Signature patient-centric device is first in class to meet new FDA reclassification requirements for blood sampling devices
SEATTLE, September 14, 2022--(BUSINESS WIRE)--Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Tasso+™ lancet as a Class II medical device. The clearance allows the company to market and sell the device to more pharmaceutical companies, healthcare organizations, and academic institutions across the country, expanding access to a simple and virtually painless blood collection experience.
The Tasso+ device is the first single-use, patient-centric blood collection product to receive Class II clearance from the FDA as part of the new reclassification process for lancets, which are intended to puncture the skin to obtain drops of capillary blood samples. This action is part of the FDA’s ongoing effort to ensure the safe and effective use of blood lancets in the home and health care settings. With this clearance, more pharmaceutical companies will be able to accelerate their decentralized clinical trials, especially for pharmacokinetic and biomarker research endpoints. Healthcare systems and physicians will also be able to use the Tasso+ device with compatible collection tubes to make determinations on blood chemistries for their patients and expand care access. Tasso+ device-based solutions with Class II clearance will be widely available to customers across the country in Q4 2022.
"With continued industry interest in decentralized clinical trials and diverse testing applications, demand for our high-quality, virtually painless, convenient blood collection solutions is at an all-time high," said Ben Casavant, PhD, CEO and co-founder of Tasso. "This FDA Class II medical device clearance will help improve patient care by relieving traditional phlebotomy-related bottlenecks and enabling more individuals to get the tests they need at the time they are needed. We are excited to unlock a new wave of large commercial opportunities for the company and to lead the industry into the future of remote testing."
For more information on the Tasso+ device-based solutions with Class II clearance, please visit www.tassoinc.com/contact.
Trusted diagnostics made easy. Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by federal grants, venture investments, and co-development agreements with industry leaders. For more information, please visit www.tassoinc.com.
Tasso, the Tasso logo, and Tasso+ are trademarks of Tasso, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220914005221/en/
Dina Schneider (206) 822-4186 x1016 media@tassoinc.com
Somerville gene therapy firm bluebird bio Inc. has netted a second key win from the U.S. Food and Drug Administration.
Biotech companies with few products on the market and red ink on the bottom line may not look like the most attractive investments right now. Here are two biotech stocks to consider buying that could make investors richer in time: Axsome Therapeutics (NASDAQ: AXSM) and CRISPR Therapeutics (NASDAQ: CRSP). Axsome Therapeutics is fresh off an important regulatory milestone.
Of the 225 million Americans who are fully vaccinated, a mere 6,278 received Novavax. It's more popular in other countries like Japan and Australia, where it's used as a booster.
A system from Edwards Lifesciences that has been cleared by the Food and Drug Administration gives patients an alternative after years of a single company dominating the market.
Is that pure luck, maybe super immunity or is it something else altogether?
Shannon Sharpe says getting tested early may have saved his life.
If you've stepped foot in a grocery store any time over the past few years, it's almost a guarantee that you have encountered some of your favorite foods in cauliflower form. From pizza to rice to even cookies, cauliflower is certainly having a moment.Thanks to its neutral flavor and its versatility, cauliflower is a natural addition to many favorite recipes. And as an added bonus, the taste is rarely compromised when this cruciferous veggie is included. It has become a solution for those who ar
It was vaccination time at Ethel Brown’s long-term-care home in the Bronx, New York. Again. Brown, 95, had already gotten four COVID shots, and while she was happy to submit to a fifth, this latest booster prompted a few questions. “Why are we getting another one?” Brown asked as she and other residents waited for their shots Wednesday. “Will this be the last booster shot?” With a jumble of confusion, eagerness and vaccine fatigue, America embarked in earnest this past week on a sprawling new ca
Iranian Supreme Leader Ayatollah Ali Khamenei, bedridden with illness after he underwent emergency gastrointestinal surgery, reportedly made a public appearance Saturday after he cancelled all meetings.
Former White House press secretary Sarah Sanders, a Republican who is running for governor in Arkansas, was released from a hospital Saturday after undergoing surgery for thyroid cancer. “Following successful surgery on Friday to remove her thyroid and surrounding lymph nodes and in consultation with her physician, Sarah was discharged from an Arkansas hospital—cancer free,” said Sanders spokesperson Judd Deere. Deere told The Associated Press that Sanders, 40, plans to resume campaigning “soon,” but it was not known precisely when she would return.
The food in the box isn’t the food on the box and that can be a problem.
After years of struggling, many changes have come to Kohl's and more are coming. Earlier this year Kohl's was facing a buyout option with Franchise Group , but after citing a volatile market, Kohl's chose to end the buyout talks. Not long after the deal fell through Kohl's began making major changes to its fashion lines.
Two dangerous and highly potent illicit drugs are increasingly infiltrating the supply of street drugs, putting people at risk for deadly overdoses.
No day goes by without us thinking about food. For most of us, taste will usually be the dominant factor in what we decide to eat, with ease, cost and, of course, nutrition, all playing a part in that decision.
Some Republicans would rather focus on the economy and border issues heading into the midterm elections.
Did you hear that COVID was canceled this fall? Spoiler alert: It’s not.
Sunny Hostin has made it clear that because of her devotion to Catholicism, she is against abortion, even in regard to sexual assault and incest.
According to the Centers for Disease Control and Prevention, "Nearly half of adults in the United States (47%, or 116 million) have hypertension, defined as a systolic blood pressure greater than 130 mmHg or a diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension." Getting your blood pressure is vital for overall health because hypertension puts you at risk for stroke and heart disease, which are leading causes of death in the U.S. "Hypertension or high blood pr
She has got thousands of followers, but what means more is how many lives she saves.
Commentary roundup: What newspapers around the state are saying